Minireviews
Copyright ©The Author(s) 2015.
World J Transplant. Dec 24, 2015; 5(4): 276-286
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.276
Figure 1
Figure 1 Suggested pre-transplant screening algorithm for cardiovascular disease. 1Diabetes mellitus, prior CVD, > 1 year on dialysis, LVH, age > 60 years, smoking, hypertension, and dyslipidemia; 2Proceed to transplantation with standard screening and frequency of testing [for patients with no abnormalities at start, standard frequency is evaluation once dry weight is achieved (1-3 mo) and prior to transplantation date]; 3Abnormalities that pose limited threat to the success of the allograft and patient’s health; 4Per cardiologist recommendation. CVD: Cardiovascular disease; MPS: Myocardial perfusion scintigraphy; DSE: Dobutamine stress echocardiography; LVH: Left ventricular hypertrophy; METS: Metabolic equivalents.